Synucleinopathies: Intrinsic and Extrinsic Factors

AK Lomeli-Lepe, JL Castañeda-Cabral… - Cell Biochemistry and …, 2023 - Springer
Abstract α-Synucleinopathies are a group of neurodegenerative disorders characterized by
alterations in α-synuclein (α-syn), a protein associated with membrane phospholipids …

Molecular mechanism of α-synuclein aggregation on lipid membranes revealed

AJ Dear, X Teng, SR Ball, J Lewin, RI Horne… - Chemical …, 2024 - pubs.rsc.org
The central hallmark of Parkinson's disease pathology is the aggregation of the α-synuclein
protein, which, in its healthy form, is associated with lipid membranes. Purified monomeric α …

[HTML][HTML] α-Synuclein pathology from the body to the brain: so many seeds so close to the central soil

Y Yang, Z Zhang - Neural Regeneration Research, 2024 - journals.lww.com
Abstract α-Synuclein is a protein that mainly exists in the presynaptic terminals. Abnormal
folding and accumulation of α-synuclein are found in several neurodegenerative diseases …

The role of Nα‐terminal acetylation in protein conformation

S Calis, K Gevaert - The FEBS Journal, 2024 - Wiley Online Library
Especially in higher eukaryotes, the N termini of proteins are subject to enzymatic
modifications, with the acetylation of the alpha‐amino group of nascent polypeptides being a …

CRISPR-based identification of N-terminal acetylation in synucleinopathies

EJ Bae, SJ Lee - Trends in Neurosciences, 2024 - cell.com
A recent study by Kumar et al. identified several biological pathways that regulate the levels
of endogenous alpha-synuclein (α-synuclein). They specifically highlighted the N-terminal …

Fibrillation of α‐synuclein triggered by bacterial endotoxin and lipid vesicles is modulated by N‐terminal acetylation and familial Parkinson's disease mutations

JR Monteiro Neto, VA Lima, C Follmer - The FEBS Journal, 2024 - Wiley Online Library
It has been hypothesized that‐‐Parkinson's disease (PD) may be initiated in the
gastrointestinal tract, before manifesting in the central nervous system. In this respect, it was …

Probing the effects of N-terminal acetylation on α-synuclein structure, aggregation and cytotoxicity

R Bell, M Vendruscolo, JR Kumita - Methods in Enzymology, 2023 - Elsevier
Parkinson's disease is associated with the aberrant aggregation of α-synuclein within brain
cells. Although the causes of this process are still unclear, post-translational modifications of …

Effect of Modification Strategies on the Biological Activity of Peptides/Proteins

J Ma, L Yan, J Yang, Y He, L Wu - ChemBioChem, 2024 - Wiley Online Library
Covalent attachment of biologically active peptides/proteins with functional moieties is an
effective strategy to control their biodistribution, pharmacokinetics, enzymatic digestion, and …

α-突触核蛋白的异常修饰及在帕金森病中的作用机制

齐雪, 李家慧, 朱远峰, 禹璐, 王鹏 - 中国组织工程研究, 2024 - cjter.com
α- 突触核蛋白的异常修饰及在帕金森病中的作用机制 Page 1 Chinese Journal of Tissue
Engineering Research|Vol 28|No.8|March 2024|1301 中国组织工程研究 Chinese Journal of …

Residues 2-7 of alpha-synuclein regulate amyloid formation via lipid-dependent and-independent pathways

KM Dewison, B Rowlinson, JM Machin, JA Crossley… - bioRxiv, 2024 - biorxiv.org
Amyloid formation by alpha-synuclein (alphaSyn) occurs in Parkinsons disease, multiple
system atrophy, and dementia with Lewy bodies. Deciphering the residues that regulate …